SC
EPZM

Slow Capital’s Epizyme, Inc EPZM Stock Holding History

Slow Capital’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44,879
Closed -$487K – 179
2020
Q4 		$487K Buy
44,879
+5,274
+13% +$65.1K 0.12% 143
2020
Q3 		$472K Buy
39,605
+16,855
+74% +$226K 0.13% 140
2020
Q2 		$365K Buy
22,750
+1,260
+6% +$22K 0.11% 142
2020
Q1 		$333K Sell
21,490
-6,707
-24% -$144K 0.13% 140
2019
Q4 		$694K Buy
28,197
+8,118
+40% +$121K 0.21% 132
2019
Q3 		$207K Sell
20,079
-1,344
-6% -$17K 0.07% 162
2019
Q2 		$269K Sell
21,423
-4,136
-16% -$53.2K 0.11% 158
2019
Q1 		$317K Buy
+25,559
New +$286K 0.13% 154

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return